Computer aided comparative analysis of the binding modes of the adenosine receptor agonists for all known subtypes of adenosine receptors

Journal of Molecular Graphics and Modelling

Volumn 25, Issue 5, 2007, Pages 740-754

  Ivanov, Andrei A ^a   Palyulin, Vladimir A ^a   Zefirov, Nikolai S ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Adenosine receptor; Agonist; Binding mode; Docking; Homology modeling

Indexed keywords

CELL MEMBRANES; COMPUTER AIDED ANALYSIS; DOCKING; MOLECULAR ORIENTATION; NITROGEN COMPOUNDS; PHYSIOLOGICAL MODELS;

ADENOSINE; HOMOLOGY MODELING; RHODOPSIN;

PROTEINS;

ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; RHODOPSIN;

ARTICLE; COMPARATIVE STUDY; COMPUTER ANALYSIS; HYDROPHILICITY; LIGAND BINDING; MOLECULAR DOCKING; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING;

ADENOSINE; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CATTLE; COMPUTER GRAPHICS; COMPUTER SIMULATION; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, PURINERGIC P1; RHODOPSIN; SEQUENCE HOMOLOGY, AMINO ACID;

BOVINAE;

EID: 33846609043     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmgm.2006.06.004     Document Type: Article

References (75)

1. Fredholm B.B., IJzerman A.P., Jacobson K.A., Klotz K.-N., and Linden J. International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors. Pharmacol. Rev. 53 (2001) 527-552
2. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50 (1998) 413-492
3. 2+ channels in rat striatal cholinergic interneurons. J. Neurophysiol. 83 (2000) 322-332
4. + channels in cerebral ischemic preconditioning. Proc. Natl. Acad. Sci. 92 (1995) 4666-4670
5. + channels. Eur. J. Biochem. 267 (2000) 5830-5836
6. 1 receptors in stably contansfected fibroblast cells. J. Biol. Chem. 273 (1998) 4718-4724
7. 2 receptors. J. Biol. Chem. 277 (2002) 18091-18097
8. 2 receptor agonist AMP 579 in a porcine model of myocardial infarction. J. Pharmacol. Exp. Ther. 286 (1998) 611-618
9. 1-receptor induced late preconditioning and myocardial infarction: reperfusion duration is critical. J. Physiol. Heart Circ. Physiol. 283 (2002) H38-H43
10. 6-(p-sulfophenyl)adenosine in diabetic zucker rats: influence of the disease on the selectivity of action. J. Pharmacol. Exp. Ther. 287 (1998) 21-30
11. 2A receptor in basal ganglia. Biosci. Biotechnol. Biochem. 65 (2001) 1447-1457
12. 2A receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation. J. Pharmacol. Exp. Ther. 294 (2000) 1034-1042
13. Barnes P.J., and Theophylline. New perspectives for an old drug. Am. J. Respir. Crit. Care Med. 167 (2003) 813-818
14. 2B receptors. Br. J. Pharmacol. 126 (1999) 1796-1800
15. 3 Adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H607-H613
16. 1 agonists with diminished hypotensive effects. J. Med. Chem. 42 (1999) 3463-3477
17. 1 adenosine receptor agonists. Bioorg. Med. Chem. 10 (2002) 1115-1122
18. 1 adenosine receptor. J. Med. Chem. 43 (2000) 250-260
19. Hutchinson A.J., Webb R.L., Oei H.H., Ghai G.R., Zimmerman M.B., and Williams M. CGS21680, a selective adenosine receptor agonist with preferential hypotensive activity. J. Pharmacol. Exp. Ther. 251 (1989) 47-55
20. 2B ligands. J. Med. Chem. 45 (2002) 3271-3279
21. 2B adenosine receptor subtype. Nucleosides Nucleotides Nucleic Acids 22 (2003) 809-812
22. 2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine. J. Med. Chem. 47 (2004) 3707-3709
23. Jacobson K.A., Ji X., Li A.-H., Melman N., Siddiqui M.A., Shin K.J., Marquez V.E., and Ravi R.G. Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists. J. Med. Chem. 43 (2000) 2196-2203
24. 3 receptor. J. Med. Chem. 46 (2003) 353-355
25. 3 adenosine receptor. J. Med. Chem. 46 (2003) 3775-3777
26. 3 adenosine receptor agonists. J. Med. Chem. 47 (2004) 5535-5540
27. 3 receptor agonists. J. Med. Chem. 47 (2004) 4766-4773
28. 2A agonists and antagonists. J. Med. Chem. 46 (2003) 4847-4859
29. 1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis. J. Biol. Chem. 267 (1992) 10764-10770
30. Ballesteros J., and Weinstein H. Integrated methods for the construction of three-dimensional models of structure-function relations in G protein-coupled receptors. Meth. Neurosci. 25 (1995) 366-428
31. Ballesteros J.A., Shi L., and Javitch J.A. Structural mimicry in G protein-coupled receptors: implication of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol. Pharmacol. 60 (2001) 1-19
32. 1 adenosine receptor mediates specific agonist binding. J. Biol. Chem. 269 (1994) 2373-2376
33. 1 adenosine receptor: influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding. Mol. Pharmacol. 50 (1996) 1635-1642
34. 1 adenosine receptor. J. Biol. Chem. 274 (1999) 3617-3621
35. 1 adenosine receptor. Mol. Pharmacol. 59 (2001) 1187-1195
36. 2A adenosine receptor. J. Biol. Chem. 270 (1995) 13987-13997
37. 2A adenosine receptors: involvement of Glu13 and His278 in ligand binding and sodium modulation. Biochem. Pharmacol. 60 (2000) 661-668
38. 2A adenosine receptors are required for ligand recognition. Mol. Pharmacol. 50 (1996) 512-521
39. 2A adenosine receptor are required for ligand recognition. Mol. Pharmacol. 49 (1996) 683-691
40. 2B receptor for 2-(1-hexynyl)adenosine. Mol. Pharmacol. 58 (2000) 1349-1356
41. 2B receptor followed by growth selection in yeast. Identification of constitutively active and gain of function mutations. Mol. Pharmacol. 65 (2004) 702-710
42. 3 adenosine receptor. J. Biol. Chem. 277 (2002) 19056-19063
43. 3 receptor with selectively enhanced affinity for amine-modified nucleosides. J. Med. Chem. 44 (2001) 4125-4136
44. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., and Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
45. Okada T., Fujiyoshi Y., Silow M., Navarro J., Landau E.M., and Shichida Y. Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc. Natl. Acad. Sci. 99 (2002) 5982-5987
46. Okada T., Sugihara M., Bondar A.N., Elstner M., Entel P., and Buss V. The retinal conformation and its environment in rhodopsin in light of a new 2.2 Å crystal structure. J. Mol. Biol. 342 (2004) 571-583
47. Boeckmann B., Bairoch A., Apweiler R., Blatter M.-C., Estreicher A., Gasteiger E., Martin M.J., Michoud K., O'Donovan C., Phan I., Pilbout S., and Schneider M. The Swiss-Prot protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res. 31 (2003) 365-370
48. 1 adenosine receptor and study of the mechanisms of its selective ligand binding. Dokl. Biochem. Biophys. 386 (2002) 271-273
49. 2A adenosine receptor. Dokl. Biochem. Biophys. 389 (2003) 94-97
50. 2B adenosine receptor and an analysis of the binding modes of its selective ligands. Mendeleev Comm. (2002) 211-212
51. 2B receptor antagonists. J. Med. Chem. 48 (2005) 6813-6820
52. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., and Higgins D.G. The ClustalX Windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25 (1997) 4876-4882
53. Šali A., and Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234 (1993) 779-815
54. Šali A., and Overington J.P. Derivation of rules for comparative protein modeling from a database of protein structure alignments. Protein Sci. 3 (1994) 1582-1596
55. Morris A.L., MacArthur M.W., Hutchinson E.G., and Thornton J.M. Stereochemical quality of protein structure coordinates. Proteins 12 (1992) 345-364
56. Laskowski R.A., MacArthur M.W., Moss D.S., and Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26 (1993) 283-291
57. Sybyl Molecular Modeling System, Version 6.9.1 (2003), Tripos Inc., St. Louis, MO
58. Takeda-Shitaka M., Takaya D., Chiba C., Tanaka H., and Umeyama H. Protein structure prediction in structure based drug design. Curr. Med. Chem. 11 (2004) 551-558
59. Mazna P., Obsilova V., Jelinkova I., Balik A., Berka K., Sovona Z., Ettrich R., Svoboda P., Obsil T., and Teisinger J. Molecular modeling of human MT2 melatonin receptor: the role of Val204, Leu272 and Tyr298 in ligand binding. J. Neurochem. 91 (2004) 836-842
60. 4 receptors. Biochem. Pharmacol. 71 (2006) 540-549
61. Costanzi S., Mamedova L., Gao Z.-G., and Jacobson K.A. Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. J. Med. Chem. 47 (2004) 5393-5404
62. De Zwart M., Kourounakis A., Kooijman H., Spek A.L., Link R., Von Frijtag Drabbe Künzel J.K., and IJzerman A.P. 5′-N-carboxamidoadenosines as agonists for adenosine receptors. J. Med. Chem. 42 (1999) 1384-1392
63. Klotz K.-N., Hessling J., Hegler J., Owman C., Kull B., Fredholm B.B., and Lohse M.J. Comparative pharmacology of human adenosine receptor subtypes-characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedebergs Arch. Pharmacol. 357 (1998) 1-9
64. Cristalli G., Camaioni E., Costanzi S., Vittori S., Volpini R., and Klotz K.-N. Characterization of potent ligands at human recombinant adenosine receptors. Drug. Dev. Res. 45 (1998) 176-181
65. 3 adenosine receptors. Naunyn-Schmiedebergs Arch. Pharmacol. 360 (1999) 103-108
66. Camaioni E., Di Francesco E., Vittori S., Volpini R., and Cristalli G. Adenosine receptor agonists: synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)NECA. Bioorg. Med. Chem. 5 (1997) 2267-2275
67. Vittori S., Camaioni E., Costanzi S., Volpini R., Klotz K.-N., and Cristalli G. Synthesis and receptor affinity of polysubstituted adenosines. Nucleosides Nucleotides 18 (1999) 739-740
68. 2B adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyl adenosine and NECA derivatives. Nucleosides Nucleotides Nucleic Acids 23 (2004) 471-481
69. Fredholm B.B., Irenius E., Kull B., and Shulte G. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem. Pharmacol. 61 (2001) 443-448
70. 2B receptor: a search for potent agonists. Nucleosides Nucleotides 17 (1998) 969-985
71. 2B receptors. Drug Dev. Res. 49 (2000) 85-93
72. 2A receptors. Ther. Pharmacol. Sci. 17 (1996) 364-372
73. 2B adenosine receptors. Drug Des. Discov. 16 (1999) 217-226
74. Robeva A.S., Woodard R.L., Jin X., Gao Z., Bhattacharya S., Taylor H.E., Rosin D.L., and Linden J. Molecular characterization of recombinant human adenosine receptors. Drug Dev. Res. 39 (1996) 243-252
75. 3 adenosine receptor. Mol. Pharmacol. 45 (1994) 1101-1111